CLVS

Clovis Oncology, Inc.

Delisted

CLVS was delisted on the 20th of December, 2022.

147 hedge funds and large institutions have $358M invested in Clovis Oncology, Inc. in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

less call options, than puts

Call options by funds: $ | Put options by funds: $

less funds holding

Funds holding:

12% less first-time investments, than exits

New positions opened: 36 | Existing positions closed: 41

28% less repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 50

Holders
147
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
2
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$114M
Puts
$118M
Net Calls
Net Calls Change

Top Buyers

1 +$27.8M
2 +$6.55M
3 +$5.21M
4
PAI
Palo Alto Investors
California
+$3.5M
5
Jane Street
Jane Street
New York
+$2.54M

Top Sellers

1 -$26M
2 -$15.7M
3 -$15.2M
4
RG
Redmile Group
California
-$14.2M
5
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$13.9M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$52.7M
2
$44M
3
$38.2M
4
$35.9M
5
$35.6M
6
$10.4M
7
$10.4M
8
$7.48M
9
$6.61M
10
$6.55M
11
$6.2M
12
$5.99M
13
$4.45M
14
$4.44M
15
$4.26M
16
$3.82M
17
$3.54M
18
$3.3M
19
$3.27M
20
$3.21M
21
$2.67M
22
$2.55M
23
$2.49M
24
$2.49M
25
$2.3M